KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $21.6 million.

  • Opko Health's Profit After Tax fell 1309.2% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.4 million, marking a year-over-year decrease of 3489.24%. This contributed to the annual value of -$53.2 million for FY2024, which is 7181.87% up from last year.
  • Opko Health's Profit After Tax amounted to $21.6 million in Q3 2025, which was down 1309.2% from -$148.4 million recorded in Q2 2025.
  • Opko Health's 5-year Profit After Tax high stood at $31.1 million for Q1 2021, and its period low was -$148.4 million during Q2 2025.
  • In the last 5 years, Opko Health's Profit After Tax had a median value of -$55.4 million in 2022 and averaged -$41.8 million.
  • As far as peak fluctuations go, Opko Health's Profit After Tax surged by 15255.7% in 2021, and later plummeted by 134047.55% in 2025.
  • Opko Health's Profit After Tax (Quarter) stood at -$73.8 million in 2021, then decreased by 15.53% to -$85.2 million in 2022, then grew by 22.0% to -$66.5 million in 2023, then skyrocketed by 121.1% to $14.0 million in 2024, then soared by 54.23% to $21.6 million in 2025.
  • Its Profit After Tax was $21.6 million in Q3 2025, compared to -$148.4 million in Q2 2025 and -$67.6 million in Q1 2025.